Jennifer Chao
Director/Board Member chez ENDO INTERNATIONAL PLC
Fortune : 10 $ au 31/03/2024
Profil
Jennifer M.
Chao is the founder of Corestrategies Management LLC, which was founded in 2008.
She is currently an Independent Director at Endo International Plc and Cardiol Therapeutics, Inc. She was formerly the Chairman of BioSpecifics Technologies Corp.
from 2019 to 2020, an Independent Director at Edesa Biotech, Inc. from 2022 to 2023, a Managing Director at RBC Capital Markets, Inc., a Research Analyst at Deutsche Bank Securities, Inc., and a Vice President at Leerink Swann & Co. Ms. Chao received her undergraduate degree from New York University in 1992.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ENDO INTERNATIONAL PLC
0,01% | 12/04/2023 | 24 921 ( 0,01% ) | 10 $ | 31/03/2024 |
29/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jennifer Chao
Sociétés | Poste | Début |
---|---|---|
ENDO INTERNATIONAL PLC | Director/Board Member | 17/02/2021 |
CARDIOL THERAPEUTICS INC. | Director/Board Member | 15/03/2022 |
Corestrategies Management LLC | Founder | 01/01/2008 |
Anciens postes connus de Jennifer Chao
Sociétés | Poste | Fin |
---|---|---|
EDESA BIOTECH, INC. | Director/Board Member | 01/06/2023 |
BIOSPECIFICS TECHNOLOGIES CORP. | Chairman | 02/12/2020 |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | 29/02/2008 |
Leerink Swann & Co. | Corporate Officer/Principal | - |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Corporate Officer/Principal | - |
Formation de Jennifer Chao
New York University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ENDO INTERNATIONAL PLC | Health Technology |
CARDIOL THERAPEUTICS INC. | Health Technology |
EDESA BIOTECH, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Finance |
Leerink Swann & Co. | Finance |
Corestrategies Management LLC |